Clinical trial
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
NCT01019694
Study timeline
Study start (unknown)2009-11-01Date precision: month
Registry last updated2014-10-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Interventions
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
St LouisMissouri, United States2CincinnatiOhio, United States2RichmondVirginia, United States2SpokaneWashington, United States2GreenvilleSouth Carolina, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1San AntonioTexas, United States1PittsburghPennsylvania, United States1TampaFlorida, United States1MinneapolisMinnesota, United States1AustinTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01019694 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.